Research and Clinical Trials

Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Results of a study on smoldering multiple myeloma presented at the 2019 American Society of Clinical Oncology Annual Meeting suggest that the cancer drug lenalidomide[...]

Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene and[...]

A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most[...]

The percentage of women who are screened for cervical cancer may actually be far lower than national statistics suggest they are, according to a Mayo[...]

A study led by Mayo Clinic researchers Zhi Zhang Yang, M.D., and Stephen M. Ansell, M.D., Ph.D., has found that healthy white blood cells called[...]

Research led by Mayo Clinic oncologists Roberto A. Leon Ferre, M.D., and Charles L. Loprinzi, M.D., has found that the drug oxybutynin helps reduce the[...]

As I write this message, the snow has finally stopped in Minnesota and the month of May is upon us — a time each year[...]

Mayo Clinic researchers have found that the oral drug apixaban is safe and effective to treat blood clots in patients undergoing cancer therapy. Apixaban was[...]

A less-invasive nipple-sparing mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer[...]